COLOMBO, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 14.966
EU - Europa 9.699
AS - Asia 3.257
SA - Sud America 330
AF - Africa 100
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
Totale 28.379
Nazione #
US - Stati Uniti d'America 14.688
IT - Italia 3.150
DE - Germania 1.996
SG - Singapore 1.232
RU - Federazione Russa 863
CN - Cina 818
SE - Svezia 683
DK - Danimarca 667
IE - Irlanda 617
GB - Regno Unito 375
UA - Ucraina 331
HK - Hong Kong 302
BR - Brasile 291
CA - Canada 248
PL - Polonia 243
VN - Vietnam 231
FR - Francia 215
IN - India 209
AT - Austria 160
FI - Finlandia 131
ID - Indonesia 129
NL - Olanda 63
KR - Corea 55
IR - Iran 54
TR - Turchia 50
EG - Egitto 46
BE - Belgio 43
CH - Svizzera 27
ES - Italia 27
IL - Israele 20
PH - Filippine 20
MX - Messico 19
PK - Pakistan 19
CZ - Repubblica Ceca 18
AR - Argentina 17
JP - Giappone 14
TW - Taiwan 13
ZA - Sudafrica 13
RO - Romania 12
HU - Ungheria 11
PT - Portogallo 11
AU - Australia 10
GR - Grecia 10
TH - Thailandia 10
EU - Europa 9
AZ - Azerbaigian 8
IQ - Iraq 8
UZ - Uzbekistan 8
BD - Bangladesh 7
KE - Kenya 7
LT - Lituania 7
MU - Mauritius 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
MO - Macao, regione amministrativa speciale della Cina 6
NO - Norvegia 6
SA - Arabia Saudita 6
SC - Seychelles 6
LV - Lettonia 5
CI - Costa d'Avorio 4
CO - Colombia 4
EE - Estonia 4
JO - Giordania 4
LU - Lussemburgo 4
MA - Marocco 4
MY - Malesia 4
PA - Panama 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AM - Armenia 2
MK - Macedonia 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 28.373
Città #
Ann Arbor 5.889
Frankfurt am Main 1.682
Milan 1.171
Woodbridge 1.034
Fairfield 1.019
Singapore 788
Chandler 707
Houston 669
Wilmington 664
Dublin 598
Ashburn 591
Seattle 406
Cambridge 360
Dearborn 332
Jacksonville 316
Santa Clara 285
Hong Kong 273
New York 260
Kraków 218
Princeton 188
Shanghai 164
Dong Ket 145
Vienna 144
Nanjing 140
Jakarta 110
Lawrence 93
Altamura 91
Toronto 84
Council Bluffs 82
Guangzhou 78
Helsinki 66
Fremont 61
Los Angeles 58
San Diego 58
Beijing 55
Florence 50
Lachine 49
Rome 49
Monza 47
London 44
Montréal 43
Nanchang 42
Moscow 38
Cairo 37
Pavia 37
Brussels 36
Hyderabad 35
Ottawa 35
Como 33
Tianjin 33
Nuremberg 31
Shenyang 30
Bologna 29
Melzo 26
Brooklyn 25
Desio 25
Sacramento 25
Boardman 24
Vercelli 24
Chicago 21
Hebei 21
Palermo 21
Turin 21
Sarno 20
São Paulo 20
Hangzhou 19
Munich 19
Old Bridge 19
Verona 19
Pune 18
Andover 17
Brescia 17
Changsha 17
Cinisello Balsamo 17
Edmonton 17
Naples 17
Sesto San Giovanni 17
Bergamo 16
Bari 15
Kiev 15
Kunming 15
Livorno 15
Mountain View 15
Carate Brianza 14
Düsseldorf 14
Falls Church 14
Jinan 14
Napoli 14
Norwalk 14
Dallas 13
Kocaeli 13
Kochi 13
Ningbo 13
Paris 13
Warsaw 12
Genova 11
Grafing 11
Jiaxing 11
Rio de Janeiro 11
Seveso 11
Totale 20.370
Nome #
MnO Nanoparticles Embedded in Functional Polymers as T1 Contrast Agents for Magnetic Resonance Imaging 509
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 509
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 507
Uniform Lipopolysaccharide (LPS)-Loaded Magnetic Nanoparticles for the Investigation of LPS–TLR4 Signaling 481
Multifunctional Magnetic Gold Nanomaterials for Cancer 476
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 476
Thirty years of cancer nanomedicine: Success, frustration, and hope 474
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 460
Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+mobilization and the inflammatory activity of dendritic cells 460
The emerging role of nanotechnology in skincare 445
Are nanotechnological approaches the future of treating inflammatory diseases? 442
Targeted delivery of nanoparticles 439
Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia 433
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 432
Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations 419
Functionalization of colloidal nanoparticles with a discrete number of ligands based on a “HALO-bioclick” reaction 419
Relaxometric studies of Gd-Chelate conjugated on the surface of differently shaped gold nanoparticles 402
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 397
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 391
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 385
Nanoparticle-Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment 383
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 381
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 380
The role of polymeric coatings for a safe-by-design development of biomedical gold nanoparticles assessed in zebrafish embryo 380
Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles 371
Monitoring the fate of orally administered plga nanoformulation for local delivery of therapeutic drugs 371
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 361
A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake 324
Bioengineered Approaches for Site Orientation of Peptide-Based Ligands of Nanomaterials 324
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 317
Half-Chain trastuzumab nanoconjugates enhance antitumor activity in HER2+ breast cancer 316
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study 315
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies 314
Suicide gene therapy: A new frontier for cancer fighting 303
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor 301
Recent advances in magnetic fluid hyperthermia for cancer therapy 301
Anti-madcam-1-conjugated nanocarriers delivering quantum dots enable specific imaging of inflammatory bowel disease 299
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 273
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 273
Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats 271
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 263
MAdCAM-1 nanotargeting uncovers bowel inflammation foci in experimental model of colitis 263
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice 262
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 259
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 258
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 249
Nano-targeting of Mucosal Addressin Cell Adhesion Molecule-1 identifies bowel inflammation foci in murine model 237
Dependence of nanoparticle-cell recognition efficiency from surface orientation of scFv targeting ligands 235
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches 231
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective 230
Nanoparticle-mediated delivery of suicide genes in cancer therapy 226
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes 223
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 220
Red and deep-red emissive polymeric nanoparticles based on polybenzofulvene and perylenediimide derivatives 219
Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells 218
O6-alkylguanine-DNA transferase (SNAP) as capture module for site-specific covalent bioconjugation of targeting protein on nanoparticles 218
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 217
Cream formulation impact on topical administration of engineered colloidal nanoparticles 213
Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells 212
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 212
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells 211
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates 208
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases 208
Characterization of Hospital and Patients’ Microbiome Biodiversity for Nano-detectors Development and Antibiotic Resistance Monitoring 203
Biotechnological approaches toward nanoparticle biofunctionalization 202
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic media 201
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties 197
Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts 195
Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells 193
Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition 191
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells 191
Click Chemistry Immobilization of Antibodies on Polymer Coated Gold Nanoparticles 188
Towards a universal method for the stable and clean functionalization of inert perfluoropolymer nanoparticles: exploiting photopolymerizable amphiphilic diacetylenes 187
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cells 187
Magnetofluorescent nanoparticles for bimodal detection of breast cancer cells 185
Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles 185
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection 184
Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells 184
Femtomolar detection of auto-antibodies by magnetic relaxation nanosensors 183
The modality of cell-particle interactions drives the toxicity of nanosized CuO and TiO2 in human alveolar epithelial cells 179
Protein Oriented Ligation on Nanoparticles Exploiting O6-Alkylguanine-DNA Transferase (SNAP) Genetically Encoded Fusion 177
HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice 176
Full‐length recombinant hsp‐d binds and inhibits sars‐cov‐2 176
Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles 174
Intracellular Drug Release from Curcumin-Loaded PLGA Nanoparticles Induces G2/M Block in Breast Cancer Cells 172
A preliminary "in vivo" study to evaluate the effects of a new drug delivery method in Chronic lung allograft dysfunction (CLAD) 169
Structural iridescent tuned colors from self-assembled polymer opal surfaces 167
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells 166
Exploring Hospital and Patient Microbiomes for Advanced Nano-detectors Development and Antibiotic Resistance Monitoring 165
Novel Biotinylated Bile Acid Amphiphiles: Micellar Aggregates Formation and Interaction with Hepatocytes 164
Strategies for the characterization of the saccharidic moiety in composite nanoparticles 162
Eco-luxury: Making sustainable drugs and cosmetics with Prosopis cineraria natural extracts 158
One-step synthesis of star-like gold nanoparticles for surface enhanced Raman spectroscopy 154
Innovative approach to safely induce controlled lipolysis by superparamagnetic iron oxide nanoparticles-mediated hyperthermic treatment 153
Biological applications of magnetic nanoparticles 151
An Innovative Approach to Selectively Inhibit Mesenchymal Cells Isolated from BOS Patients 150
Resolving the structure of ligands bound to the surface of superparamagnetic iron oxide nanoparticles by hrmas nmr spectroscopy 145
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 140
Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2 140
Multiple presentation of scFv800E6 on silica nanospheres enhances binding efficacy toward HER-2 receptor in breast cancer cells 136
Totale 27.236
Categoria #
all - tutte 83.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020748 0 0 0 0 0 0 0 0 0 304 283 161
2020/20215.301 207 264 454 431 423 528 450 509 453 583 388 611
2021/20224.038 446 411 415 411 228 277 301 311 237 277 273 451
2022/20234.359 524 1.019 524 445 401 576 115 174 280 104 109 88
2023/20242.516 118 72 145 132 274 466 492 102 132 98 142 343
2024/20255.253 355 456 697 376 591 345 553 316 749 815 0 0
Totale 29.405